WHO ICTRP trial
Xuanju Compound Capsule VS Terazosin in treatment of chronic prostatitis: a…
ACTRN12613000885796 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12613000885796 |
|---|---|
| Public title | Xuanju Compound Capsule VS Terazosin in treatment of chronic prostatitis: a Prospective Randomized Controlled Trial |
| Scientific title | Xuanju Compound Capsule compared with Terazosin in treatment of patients with chronic prostatitis: evaluation of symptom and NIH-CPSI |
| Primary sponsor | zhou tie |
| Secondary sponsors | sun yinghao |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | China;Korea, Democratic People's Republic Of |
| Conditions | chronic prostatitis; chronic prostatitis;Renal and Urogenital - Other renal and urogenital disorders;Alternative and Complementary Medicine - Other alternative and complementary medicine |
| Interventions | xuanju compound capsule in treatment of chronic prostatitis; 1.26mg oral administrated 3 times daily for 12 weeks; keeping diary for taking medicine |
| Registration date | Aug 8, 2013 |
| Target size | 1000 |
| Secondary IDs | Nil |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: